Comparison of an aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients

Clinical Infectious Diseases

Volumn 52, Issue 10, 2011, Pages 1218-1226

  Luong, Me Linh ^a   Clancy, Cornelius J ^a   Vadnerkar, Aniket ^a   Kwak, Eun Jeong ^a   Silveira, Fernanda P ^a   Wissel, Mark C ^b   Grantham, Kevin J ^b   Shields, Ryan K ^a   Crespo, Maria ^a   Pilewski, Joseph ^a   Toyoda, Yoshiya ^a   Kleiboeker, Steven B ^b   Pakstis, Diana ^a   Reddy, Sushruth K ^b   Walsh, Thomas J ^c   Nguyen, M Hong ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Viracor IBT Laboratories   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; GALACTOMANNAN; VORICONAZOLE;

ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; FUNGAL COLONIZATION; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG ASPERGILLOSIS; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOULD; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL LABORATORY TECHNIQUES; DNA, FUNGAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INVASIVE PULMONARY ASPERGILLOSIS; LUNG TRANSPLANTATION; MALE; MANNANS; MIDDLE AGED; MYCOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION;

EID: 79955397135     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir185     Document Type: Article

References (35)

1. Iversen M, Burton CM, Vand S, et al. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007; 26:879-86. (Pubitemid 350077208)
2. Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997; 112:1160-4. (Pubitemid 27497842)
3. Singh N. Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management. Med Mycol 2005; 43(Suppl 1):S267-70. (Pubitemid 41038577)
4. Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12:220-9.
5. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62:341-7.
6. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
7. Husain S, Kwak EJ, Obman A, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004; 4:796-802. (Pubitemid 38637580)
8. Clancy CJ, Jaber RA, Leather HL, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007; 45: 1759-65. (Pubitemid 46933903)
9. Pasqualotto AC, Xavier MO, Sanchez LB. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation 2010; 90:306-11.
10. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004; 42:5517-22. (Pubitemid 39664330)
11. Rantakokko-Jalava K, Laaksonen S, Issakainen J, et al. Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis. J Clin Microbiol 2003; 41:4304-11. (Pubitemid 37099700)
12. Sanguinetti M, Posteraro B, Pagano L, et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2003; 41:3922-5. (Pubitemid 36994742)
13. Spiess B, Buchheidt D, Baust C, et al. Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol 2003; 41:1811-8. (Pubitemid 36576496)
14. Verweij PE, Latge JP, Rijs AJ, et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995; 33:3150-3.
15. Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther 2009; 7:1201-1.
16. Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 2007; 24:89-94. (Pubitemid 47025141)
17. White PL, Bretagne S, Klingspor L, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010; 48:1231-40.
18. Centers for Disease Control and Prevention. Current CLIA Regulations (including all changes through 01/24/2004) Available at: http:// wwwn.cdc.gov/clia/regs/toc.aspx. Accessed 28 January 2011.
19. Walsh TJ, Grantham K, Kasai K, et al. Molecular diagnosis of experimental invasive pulmonary Aspergillus (IPA): preclinical development and validation for non-Aspergillus spp [poster M-1091]. In: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, MA: American Society of Microbiology, 2010.
20. Walsh TJ, Reddy S, Kasai M, et al. Molecular detection, quantification, and species-specific identification of medically important Aspergillus species by quantitative PCR: a pilot study [abstract P-058]. Program and Abstracts of Focus on Fungal Infections vol 16. Las Vegas, Nevada, March 8-10, 2006.
21. Trajman A, Luiz RR. McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest 2008; 68:77-80. (Pubitemid 351161511)
22. Loeffler J, Hebart H, Bialek R, et al. Contaminations occurring in fungal PCR assays. J Clin Microbiol 1999; 37:1200-2. (Pubitemid 29140641)
23. Verweij PE, Klont RR, Donnelly JP. Validating PCR for detecting invasive aspergillosis. Br J Haematol 2004; 127:235-6. (Pubitemid 39371823)
24. Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 2009; 22:447-65.
25. Bart-Delabesse E, Basile M, Al Jijakli A, et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005; 43:5214-20. (Pubitemid 41484028)
26. Feldmesser M. Role of neutrophils in invasive aspergillosis. Infect Immun 2006; 74:6514-6. (Pubitemid 44913125)
27. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100:171-8. (Pubitemid 26062511)
28. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 1986; 81:249-54. (Pubitemid 16018864)
29. Alexander BD, Smith PB, Davis RD, Perfect JR, Reller LB. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol 2010; 48:4083-8.
30. Park SY, Kim SH, Choi SH, et al. Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients. Transpl Infect Dis 2010; 12:309-15.
31. Vadnerkar A, Clancy CJ, Nguyen MH. Invasive mould infections of the lungs among lung transplant recipients manifest a wide range of computed tomography findings that correlate with outcome [poster 1270]. Program and Abstracts of 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver. Canada, 2010.
32. Iwen PC, Rupp ME, Langnas AN, Reed EC, Hinrichs SH. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 1998; 26:1092-7. (Pubitemid 28215471)
33. Lass-Florl C, Griff K, Mayr A, et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005; 131:201-7. (Pubitemid 43899686)
34. Sutton DA, Sanche SE, Revankar SG, Fothergill AW, Rinaldi MG. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 1999; 37:2343-5. (Pubitemid 29277804)
35. Walsh TJ, Petraitis V, Petraitiene R, et al. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 2003; 188:305-19. (Pubitemid 36898165)